Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, p (Q44715372)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, p |
scientific article |
Statements
1 reference
Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, p (English)
1 reference
Jukka Takala
1 reference
Jan Bakker
1 reference
Robert Grover
1 reference
Angela McLuckie
1 reference
Laurent Holzapfel
1 reference
Jan Andersson
1 reference
Robert Lodato
1 reference
David Watson
1 reference
Steven Grossman
1 reference
Jill Donaldson
1 reference
Glaxo Wellcome International Septic Shock Study Group
1 reference
1 January 2004
1 reference
1 reference
Identifiers
1 reference